4-hydroxy-2-oxoglutarate aldolase 1
آخر تحديث 18 Aug 2020
يتوافق مع الإرشادات التحريرية
- تنزيلتنزيل
- مشاركة
- Language
- نقاش
- Ask Patient
- نسخة صوتية
- أضف إلى المصادر المفضلة على جوجل
ال HOGA1 gene provides instructions for making the 4-hydroxy-2-oxoglutarate aldolase (HOGA) enzyme. This enzyme is found in liver and kidney cells, specifically within structures called mitochondria, which are the energy-producing centers in cells. The HOGA enzyme is involved in breaking down a protein building block (amino acid) called hydroxyproline. Specifically, during the breakdown process, HOGA cuts (cleaves) a substance called 4-hydroxy-2-oxoglutarate to produce two smaller substances called pyruvate and glyoxylate. In mitochondria, pyruvate is likely involved in energy production, but the function of glyoxylate is unclear.
اختيارات الفيديو لـ Genesمكتبة الفيديو
Normal function
ال HOGA1 gene provides instructions for making the 4-hydroxy-2-oxoglutarate aldolase (HOGA) enzyme. This enzyme is found in liver and kidney cells, specifically within structures called mitochondria, which are the energy-producing centers in cells. The HOGA enzyme is involved in breaking down a protein building block (amino acid) called hydroxyproline. Specifically, during the breakdown process, HOGA cuts (cleaves) a substance called 4-hydroxy-2-oxoglutarate to produce two smaller substances called pyruvate and glyoxylate. In mitochondria, pyruvate is likely involved in energy production, but the function of glyoxylate is unclear.
Conditions referring to this gene or chromosome
Other names
DHDPS2
DHDPSL
dihydrodipicolinate synthase-like, mitochondrial
dihydrodipicolinate synthetase homolog 2
Related patient information and medicines

Patient information leaflet
التهاب الشرايين ذو الخلايا العملاقة
Giant cell (temporal) arteritis is uncommon. It mainly affects people over the age of 70 years. It is extremely rare for it to occur in people under the age of 50. Women are more commonly affected than men. Studies in the United States have suggested that about 1 in 100 women develop this in their lifetime and about 1 in 200 men. It is most common.

Patient information leaflet
السكري من النوع 2
Type 2 diabetes can occur at أي age, including during childhood, but it occurs mainly in people aged over 40. The first-line treatment is diet, weight control and physical activity. This means that you need more insulin than you normally make to keep the blood sugar (glucose) level down; or A combination of the above two ... You can learn more.

Patient information leaflet
هل يمكنني تناول الجلوكومانان والنكسبلانون معًا؟
Glucomannan هو a type of fibre that can slow down or reduce how much of your contraceptive medication is absorbed into your bloodstream. Water / Fluids (General) You must take glucomannan with plenty of water (at least 1 to 2 glasses) to ensure it reaches your stomach. لدينا Medicines Interaction Checker helps تعتقد check whether your prescriptions,.

Patient information leaflet
مرض ويلسون
مرض ويلسون is a genetic disorder in which copper builds up in the body, mainly in the liver and brain. Without any treatment, the build-up of copper can cause serious symptoms. Treatment is with medication to remove the excess copper and/or to prevent a further build-up of copper. What is Wilson's disease. Wilson's disease is a condition.

Patient information leaflet
هل يمكنني تناول مكملات الألياف والميتفورمين معًا؟
Taking fibre supplements at the same time as metformin may slightly lower the amount of medicine your body absorbs. Our مدقق تفاعلات الأدوية helps you check whether your prescriptions, over-the-counter medicines, and supplements are safe إلى take together. إخلاء المسؤولية This information is for general educational purposes only and should not.

Patient information leaflet
إسهال حمض الصفراء
إسهال حمض الصفراء هو common, especially in people who are thought to have irritable bowel syndrome. Bile acid diarrhoea may be caused by a problem with the bowel. ... Increased levels indicate bile acid diarrhoea. The National Institute for Health and Care Excellence (NICE) issued guidance in 2021 on the use of SeHCAT to diagnose bile acid.
قراءة إضافية ومراجع
- 4-hydroxy-2-oxoglutarate aldolase 1; MedlinePlus, National Library of Medicine.
- Cochat P, Rumsby G. Primary hyperoxaluria. N Engl J Med. 2013 Aug 15;369(7):649-58. doi: 10.1056/NEJMra1301564. No abstract available.
- Hoppe B. The enzyme 4-hydroxy-2-oxoglutarate aldolase is deficient in primary hyperoxaluria type III. Nephrol Dial Transplant. 2012 Aug;27(8):3024-6. doi: 10.1093/ndt/gfs308. No abstract available.
- Milliner DS, Harris PC, Sas DJ, Lieske JC. Primary Hyperoxaluria Type 3. 2015 Sep 24 [updated 2023 Feb 9]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK316514/
- Riedel TJ, Johnson LC, Knight J, Hantgan RR, Holmes RP, Lowther WT. Structural and biochemical studies of human 4-hydroxy-2-oxoglutarate aldolase: implications for hydroxyproline metabolism in primary hyperoxaluria. PLoS One. 2011;6(10):e26021. doi: 10.1371/journal.pone.0026021. Epub 2011 Oct 6.
- Williams EL, Bockenhauer D, van't Hoff WG, Johri N, Laing C, Sinha MD, Unwin R, Viljoen A, Rumsby G. The enzyme 4-hydroxy-2-oxoglutarate aldolase is deficient in primary hyperoxaluria type 3. Nephrol Dial Transplant. 2012 Aug;27(8):3191-5. doi: 10.1093/ndt/gfs039. Epub 2012 Mar 5.
تاريخ المقال
المقال متاح أيضًا باللغة الإنجليزية, الألمانية, إسبانية, الفرنسية, إيطالي, البرتغالية, الهندية, العبرية, العربية ,، و السويدية.
18 Aug 2020 | أحدث إصدار
1 Dec 2015 | نُشر في الأصل
شارك أفكارك أو تجاربك مع الآخرين في مجتمعات المرضى.
اشترك في النشرة الإخبارية للمرضى
جرعتك الأسبوعية من النصائح الصحية الواضحة والموثوقة - مكتوبة لمساعدتك على الشعور بالاطلاع والثقة والتحكم.
من خلال الاشتراك، فإنك تقبل سياسة الخصوصية. يمكنك إلغاء الاشتراك في أي وقت. نحن لا نبيع بياناتك أبدًا.

